SpyGlass Pharma, Inc. (SGP)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
SGP price, last 12 months
Key stats
- Previous close
- $29.68
- Open
- $29.73
- Day range
- $27.94 – $31.21
- 52-week range
- $17.06 – $39.92
- Volume
- 86.4K
- Avg volume (20 days)
- 122.9K
- Market cap
- $1.1B
Performance
Technicals and fundamentals
About SpyGlass Pharma, Inc.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $1.1B